These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24893506)

  • 1. [Stomach cancer. Morphology].
    Nasierowska-Guttmejer A; Majewski P; Malinowska M
    Pol J Pathol; 2013 Dec; 64(4 Suppl 2):s27-39. PubMed ID: 24893506
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the possibilities of targeted therapy for gastric cancer].
    Zavalishina LÉ; Andreeva IuIu; Frank GA
    Arkh Patol; 2012; 74(4):21-6. PubMed ID: 22997951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese expert consensus on the molecular-targeted therapy for HER-2-positive advanced gastric cancer].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):315-9. PubMed ID: 23985265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toward more understanding of esophagogastric cancer].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):801-3. PubMed ID: 22335942
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospective analysis of the prognostic significance of DNA ploidy patterns in gastric cancer.
    Tirindelli Danesi D; Cucchiara G; Picconi A; Daffinà M; Fabiano A; Antonini F; Toscano MG; Pasqualetti P; Altavista P; Cordelli E; Spanò M
    Eur J Histochem; 1997; 41 Suppl 2():147-8. PubMed ID: 9859824
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
    Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
    J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
    Cavanna L; Rocchi A; Gorgni S; Ambroggi M; Foroni RP; Ubbiali A; Civardi G
    J Clin Oncol; 2011 May; 29(13):e367-8. PubMed ID: 21300922
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastric cancer and adjuvant chemoradiotherapy: when and where, that's the question.
    Kantzou I; Sarris G; Poulizi M; Zygogianni A; Liakakos T; Kouvaris J; Bountouroglou N; Kouloulias V
    J BUON; 2011; 16(3):473-7. PubMed ID: 22006753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal junction carcinoma multimodal treatment: standards, debate and new therapeutic options.
    Liakakos T; Katsios C; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):1-4. PubMed ID: 21309665
    [No Abstract]   [Full Text] [Related]  

  • 10. HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.
    Inui T; Asakawa A; Morita Y; Mizuno S; Natori T; Kawaguchi A; Murakami M; Hishikawa Y; Inui A
    J Intern Med; 2006 Nov; 260(5):484-7. PubMed ID: 17040255
    [No Abstract]   [Full Text] [Related]  

  • 11. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
    Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of EGF, c-erbB-2 and EGFR in intestinal variant of gastric adenocarcinomas.
    Docea AO; Mitruţ P; Cernea D; Georgescu CC; Olimid D; Mărgăritescu C; Dumitrescu D
    Rom J Morphol Embryol; 2013; 54(3):545-54. PubMed ID: 24068402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of the stomach.
    Pezet D; Michel P; Rebischung C; Ychou M
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S16-2S23. PubMed ID: 17151559
    [No Abstract]   [Full Text] [Related]  

  • 14. Extreme variability of Her-2 expression in gastric cancer.
    Balzarini P; Manenti S; Gatta LB; Villanacci V
    Dig Liver Dis; 2013 Jul; 45(7):616. PubMed ID: 23477867
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does the 7th TNM edition fit in gastric cancer management?
    Rausei S; Dionigi G; Boni L; Rovera F; Dionigi R
    Ann Surg Oncol; 2011 May; 18(5):1219-21. PubMed ID: 20878488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastric cancer: (neo-)adjuvant treatment].
    Fischbach W
    Dtsch Med Wochenschr; 2012 Sep; 137(37):1822-4. PubMed ID: 22956228
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma.
    Hicks DG; Whitney-Miller CL
    Biotech Histochem; 2013 May; 88(3-4):121-31. PubMed ID: 23293935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the protein expression and gene amplification of HER2 in gastric cancer].
    Liu JL; Li ZK; Xin FJ; Zhao H; Zhao W; Gao Y; Hu JL; Zhang XX; Zhang MS; Zhang BY; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):898-901. PubMed ID: 24062004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report.
    Al-Batran SE; Ruppert M; Jäger E
    Onkologie; 2011; 34(1-2):42-5. PubMed ID: 21346384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.